Bank7 Corp., based in Oklahoma City, will announce its financial results for the third quarter ending September 30, 2026, before the market opens on October 15, 2026. The company will hold a conference call at 9:00 a.m. CST that day to discuss the results with investors. Bank7 operates 12 branches across Oklahoma, Dallas/Fort Worth, and Kansas, focusing on serving business owners with tailored loan and deposit products. The company plans to grow through selective branch openings and strategic acquisitions.
Bank7 Corp.'s upcoming Q3 2026 earnings call is noted here with Pluang's Financials sector market data for context. For readers following Financials, here is Pluang's market snapshot as of Oct 06, 2026 19:45 WIB: Out of 85 priced Financials-sector US stocks tradable on Pluang, 71 rose and 7 fell today. Notable movers include BCS (Barclays PLC) at USD 24.02 with a 1-day change of +1.82% and 100% sell order activity, RIOT (Riot Platforms Inc) at USD 19.64 with +1.66% and 91% buy order activity, and HSBC (HSBC Holdings plc) at USD 98.07 with +1.44% and 54% buy order activity.
Morgan Stanley analyst Bob Huang lowered American International Group's (AIG) price target to $80 from $81, with the stock trading around $76, indicating potential upside. AIG is set to report its Q3 2026 earnings on November 3, with investors focuse...
Vertiv Holdings, a maker of power and cooling equipment for data centers, faces mixed analyst opinions with GLJ Research rating it a "Sell" and BMO Capital giving an "Outperform" rating. Despite a recent stock pullback, the company reported a 241% in...
Apogee Enterprises reported strong fiscal Q2 results with adjusted earnings of $1.17 per share, nearly double the estimated $0.59, and revenue of $391.14 million, surpassing expectations of $362.6 million. This marks a continued trend of beating esti...
McKesson received a bullish price target of $977 from Morgan Stanley, suggesting a 6.7% upside from its current price of $915.45. The company agreed to acquire Option Care Health for $32.05 per share, valuing the deal at approximately $5.8 billion in...
Ameriprise Financial has authorized an additional $5.5 billion for share repurchases through September 2028, supported by $2.1 billion in excess capital and $2.8 billion in liquidity. The company returned $1.9 billion to shareholders in H1 2026, incl...
